All Comparisons/Mango Medical vs Brainomix

VNDRIQ — Vendor Comparison

Mango Medical vs Brainomix

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Mango Medical53
Brainomix65

Mango Medical

Medical Imaging AI

Verification pending

Brainomix

Medical Imaging AI

Verification pending

VNDRIQ Scores

53

Overall

Privacy Score62
Governance Score33
Healthcare Readiness50
AI Risk Score65

65

Overall

Privacy Score61
Governance Score71
Healthcare Readiness63
AI Risk Score65

Approval Tier

Restricted / Review Required
Approved With Restrictions

BAA Status

Verify Directly
Available for US-based healthcare providers as part of enterprise service agreements and clinical deployments.

PHI Exposure Risk

Medium
Medium

AI Training Risk

Medium
Medium

HIPAA Risk Level

Medium
Medium

Review Frequency

—

Quarterly

Recommended Use

—

Automated AI imaging analysis for acute stroke assessment (e-ASPECTS, e-CTA, Triage) and lung fibrosis evaluation (e-Lung).

Restrictions

—

Intended for use by trained professionals only; not intended for mobile diagnostic use for certain modules like e-CTA; use is restricted to specific FDA-cleared indications.

Executive Summary

Mango Medical

Medical Imaging AI

Mango Medical is classified as Restricted / Review Required with a BAA status of Verify Directly. PHI exposure is rated Medium and AI training risk is Medium.

62

Privacy

33

Governance

50

Healthcare

65

AI Risk

Brainomix

Medical Imaging AI

Brainomix is classified as Approved With Restrictions with a BAA status of Available for US-based healthcare providers as part of enterprise service agreements and clinical deployments.. PHI exposure is rated Medium and AI training risk is Medium. Automated AI imaging analysis for acute stroke assessment (e-ASPECTS, e-CTA, Triage) and lung fibrosis evaluation (e-Lung).

61

Privacy

71

Governance

63

Healthcare

65

AI Risk

Recommended For

Mango Medical

Currently under review — not recommended for active PHI deployment

Brainomix

Automated AI imaging analysis for acute stroke assessment (e-ASPECTS, e-CTA, Triage) and lung fibrosis evaluation (e-Lung).

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

Governance Considerations

Mango Medical

BAA has not been confirmed. Execute BAA before processing PHI.

Brainomix

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Intended for use by trained professionals only; not intended for mobile diagnostic use for certain modules like e-CTA; use is restricted to specific FDA-cleared indications.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.